silkroadmed.com - SILK Company Value to Revenue Ratio

Public company logo of Silk Road Medical (SILK)

The EV/Sales valuation of Silk Road Medical, Inc (SILK) reflects the business dynamics of a company whose TCAR technology for stroke prevention has reached maturity. The minimally invasive approach of Silk Road Medical, Inc (SILK) reduces hospital expenses and waste volume, supporting ESG principles. The current value is , although a narrow profile and pressure from insurers create certain risks for the stability of the share price.

SILK Silk Road Medical, Inc: EV/Sales Multiple in the range 07/04/2022 - 11/20/2026

SILK (Silk Road Medical Inc.): analytical breakdowns and indicator data

- money and cash flow information:
Fundamental valuation:Silk Road Medical, Inc SILK
Mass-produced product of Silk Road Medical, Inc.

The investment attractiveness of Silk Road Medical, Inc (SILK) is based on high catheter assembly line utilization and the pristine condition of its production assets. This metric compares the total enterprise value, including net debt, to generated revenue, allowing for an assessment of the real value of each dollar of sales. By analyzing the EV/Sales ratio, an investor determines the degree to which the asset is overvalued relative to its fundamental operating capacity.

Competitor analysis for Silk Road Medical, Inc

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio iridex.com|Company Value to Revenue Ratio INBS (Intelligent Bio Solutions Inc.)|Company Value to Revenue XAIR (Beyond Air, Inc.)|PFSA - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple SSKN (STRATA Skin Sciences Inc.)|GCTK - Company Value to Revenue|NAOV: Company Value to Revenue|Total Company Value-to-Revenue Ratio Venus Concept Inc. VERO|Nuwellis, Inc. (NUWE) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple aethlonmedical.com (AEMD)|Enterprise Value-to-Revenue Ratio Asensus Surgical|AVGR: Business Value to Revenue|Company Value to Revenue BSGM (BioSig Technologies, Inc.)|Total Company Value-to-Revenue Ratio Cutera Inc|Know Labs, Inc. - Company Value to Revenue|NARI: Company Value to Revenue Ratio|NVRO - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio reshapelifesciences.com RSLS